Intelligent Fingerprinting’s Simple Saliva-based COVID-19 Test Now CE Marked and Available for Sale
October 25 2021 - 3:16AM
Business Wire
- Saliva-based approach revolutionises COVID-19 lateral flow
testing, with easier test suitable for vulnerable and younger
people
- Ready to support COVID-19 testing in schools, workplaces,
universities, care homes, healthcare and public events
- Cambridge, UK manufacturing facility set to produce four
million tests per month
- Read full press release or watch video
Intelligent Fingerprinting has announced that its saliva-based
COVID-19 test now carries CE marking and is available for sale. The
new VSS-GP COVID-19 Saliva Test uses a simple swab to collect
saliva from just inside the cheek, providing a much easier
alternative to current throat and nose tests that can cause
gagging, sneezing or distress during sample collection.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20211025005324/en/
The new VSS-GP COVID-19 Saliva Test from
Intelligent Fingerprinting uses a simple swab to collect saliva
from just inside the cheek, providing a much easier alternative to
current throat and nose tests that can cause gagging, sneezing or
distress during sample collection. (Photo: Business Wire)
Easier, more comfortable COVID-19 testing
Intelligent Fingerprinting’s reliable and easy-to-use
saliva-based lateral flow test supports frequent COVID-19 testing
for applications including schools, workplaces, care homes,
healthcare, airports, sports events, concerts and prisons.
Keeping plastic usage to a minimum
The Intelligent Fingerprinting COVID-19 test strip uses minimal
plastic. It has none of the plastic housing usually associated with
lateral flow tests, helping to significantly reduce its
environmental impact. The test strip is around 95% lighter than
traditional lateral flow devices, reducing the environmental impact
of packaging and transportation.
Intelligent Fingerprinting’s Executive Chairman, Philip Hand:
“Regular COVID-19 testing continues to be part of our everyday
lives, so it’s essential that we make the whole process as simple
and comfortable as possible. Our saliva-based test directly
addresses this challenge, combining much simpler sample collection
with high levels of accuracy. I’m delighted that our test is now CE
marked, and we anticipate strong demand from markets around the
world.”
How it works
A swab is used to collect the saliva sample from the inside of
the lower cheek, which is then mixed with a reagent buffer that has
been pre-added to the collection tube in order to release the virus
into the solution. The screening test is performed by inserting the
tip of the test strip into the sample, providing a positive or
negative result at 20 minutes. No instrumentation is required. The
test uses gold immunonanoparticle technology to enable the visual
detection of bound antigen via a control line and a red line on the
test strip when a saliva sample is positive for the SARS-CoV-2
antigen.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211025005324/en/
Cheryl Billson cheryl.billson@commacomms.com
+44 (0)7791 720460